News

Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
Recursion Pharmaceuticals: Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
Recursion (NASDAQ: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives today announced the acquisition of ...
Recursion Pharmaceuticals stock soars after acquiring HPP treatment from Rallybio
Investing.com -- Recursion Pharmaceuticals Inc (NASDAQ: RXRX) stock surged 11.5% while Rallybio Corp (NASDAQ: RLYB) shares jumped 35% Monday after Recursion acquired full rights to REV102, an oral ...
Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals
Detailed price information for Rallybio Corporaton (RLYB-Q) from The Globe and Mail including charting and trades.
Cantech Letter5d
Doctors Are Being Outpaced by AI-Powered Algorithms — Here’s What It Means for Investors
USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 7, 2025 /CNW/ — USA News Group News Commentary – This week in Geneva, the World Health Organization ...
Doctors Are Being Outpaced By AI-Powered Algorithms - Here's What It Means For Investors - Financial News Media
As a physician-centric, AI-powered organization, Astrana sees the acquisition as a way to scale its proactive, high-quality care model using proprietary tech and data infrastructure. The company ...
USA News Group: Doctors Are Being Outpaced by AI-Powered Algorithms -- Here's What It Means for Investors
USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 7, 2025 /PRNewswire/ -- USA News Group News Commentary - This week in Geneva, the World Health ...
The Hidden AGI: Why the Real AI Revolution May Already Be Here -- and How to Invest Before It Breaks Cover
The military's track record of developing classified technology decades before public release suggests AGI may already exist.
The Real Cost Of AI Job Loss: How We’re Losing Purpose And Paychecks
As AI replaces labor and optimizes life, the real risk isn’t extinction, it’s the loss of meaning, identity, and human ...
The AI Content Paradox: Why Lawyers Who Refuse to Market Authority Are at Risk
In an era where AI will judge you before a client ever does, authority is no longer a luxury—it’s the key to future-proofing ...
GEN - Genetic Engineering and Biotechnology News5d
Democratizing Artificial Intelligence in Pre-Clinical Drug Discovery
While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.
The future of generative AI will be free, but the cost is you
The monetisation will happen inside the output itselfJust like product placement in tv/films or billboards in GTA games, brands will preload creative assets into a global ad library. But this time, ...